Mannitol Market

How big is Mannitol Market in 2026?

USD 543.0 Million in 2026 and USD 1048.3 Million by 2036 at a 6.8% CAGR.

Sales of mannitol are estimated to grow at 6.8% from USD 543.0 Million in 2026 to USD 1048.3 Million by 2036, up from USD 508.4 Million in 2025. Buyers use mannitol for a combination of sweetness, low moisture uptake, flow control and solid-dose functionality. In July 2026, the U.S. Food and Drug Administration continued to list mannitol as a non-nutritive sweetener, anticaking or free-flow agent and formulation aid, reinforcing its multi-function role across food processing and excipient use.

The growth mechanism differs by country. South Korea maintains a current Food Additives Code and recorded a D-mannitol import clearance in March 2026, while the UK lists E421 as an approved sweetener subject to food-specific conditions. In pharmaceutical use, route and dosage form shape excipient qualification in the United States, and Japan applies designated-additive and use-standard controls. This specification-led buying pattern connects mannitol demand to the wider sugar alcohol market, where formulation performance and regulatory fit matter alongside delivered cost.

Key Takeaways of Mannitol Market

• Mannitol demand is anchored in a dual functional role: food formulators use it for sweetness and moisture-management functions, while pharmaceutical formulators value low hygroscopicity and engineered tableting performance.
• Crystal leads the Form category with a 63.1% share in 2026 because crystalline grades fit established food handling and excipient workflows across dusting, bulking, blending, and solid-dose formulation.
• Qualification evidence is becoming a stronger differentiator in pharmaceutical mannitol. Recent supplier actions around nitrosamine testing and excipient GMP or GDP certification give buyers more material for risk review without changing the underlying molecule.
• Food leads the End Use category with a 26.2% share in 2026 because mannitol can provide sweetness, anticaking behavior, and moisture control across confectionery and other permitted food applications.
• The principal friction is application-specific compliance. Food-use limits and labeling rules narrow certain recipes, while pharmaceutical switching can require compendial, quality, impurity, and supply-chain documentation.
• Profiled companies are Roquette Frères, SPI Pharma, Cargill, Merck KGaA, B Food Science Co., Ingredion Incorporated, Univar Solutions, Zhejiang Huakang Pharmaceutical Co., Ltd., American International Foods, and Foodchem International.

Analyst Perspective

Mannitol demand converts into realized revenue only when functional performance is matched by application-specific compliance and supply documentation; commodity availability alone is not enough for higher-value pharmaceutical grades.

- Nandini Roy Choudhury, Principal Analyst at Future Market Insights

How is the Mannitol Market segmented?

Form: Crystal and Powder. End Use: Food, Beverages, Pharmaceuticals, Carbonated Drinks, Bakery Goods, Confectionery, Powdered Drinks and Mixes, and Solid dosage forms.

By Form, the market includes Crystal and Powder. By End Use, the market includes Food, Beverages, Pharmaceuticals, Bakery Goods, Confectionery, Carbonated Drinks, Powdered Drinks and Mixes, and Solid Dosage Forms. Carbonated Drinks and Powdered Drinks and Mixes are tracked as distinct sub-segments within the broader Beverages category. These categories separate the physical format sold from the application in which buyers consume the ingredient. The structure also captures a market that spans routine food handling and higher-documentation pharmaceutical uses.

Why does Crystal lead demand within the Form category?

Crystal mannitol aligns with the material's established commercial identity as a white crystalline solid that can be supplied in controlled particle sizes. Buyers can use crystalline material directly or select finer and engineered grades for specific processing needs. The format works across food dusting and sweetening uses as well as pharmaceutical filling and tableting workflows, giving suppliers one core physical platform that can be tuned for different handling requirements.

• Crystal holds 63.1% of the Form category in 2026. Its position reflects broad handling familiarity and the ability to serve commodity food functions as well as specification-based excipient requirements.
• In July 2026, the FDA's food-substance inventory continued to identify mannitol for free-flow, anticaking, sweetening, and formulation functions. The range of recognized technical effects illustrates why crystalline material remains useful across multiple dry-processing settings.

Why does Food lead demand within the End Use category?

Food applications absorb mannitol where formulators need mild sweetness together with low hygroscopicity, reduced stickiness and useful bulking behavior. Confectionery is a visible use case, while bakery products and powdered mixes extend the addressable food base. That multifunctionality makes mannitol relevant to the wider food additive market, although each recipe still has to meet the applicable use and labeling conditions.

• Food holds 26.2% of the End Use category in 2026. The segment benefits from mannitol's combined sweetening, bulking, anticaking, and moisture-management functions in permitted formulations.
• The UK government's June 2026 additive list identifies E421 as mannitol and notes that many additives remain subject to food-specific quantitative limits. That combination of established authorization and formulation-specific limits is representative of the purchasing environment for food-grade material.

What are the drivers, restraints and opportunities in the Mannitol Market?

Food and solid-dose formulators value mannitol's low-hygroscopic and processing properties, while application-specific regulatory and qualification requirements constrain substitution, and engineered pharmaceutical grades create an opportunity for higher-value documented supply.

• Driver: Functional demand spans sugar-reduced food formulations and direct-compression pharmaceutical applications.
• Restraint: Use limits, labeling obligations, and pharmaceutical qualification requirements can delay adoption or supplier switching.
• Opportunity: Engineered low-hygroscopic grades with stronger quality documentation can capture formulation work that commodity mannitol does not serve well.

Why does functional versatility keep mannitol in formulation pipelines?

The main demand driver is functional versatility at the point of formulation. FDA records updated in July 2026 recognize mannitol as a non-nutritive sweetener and as an anticaking or free-flow agent. Pharmaceutical suppliers also market particle-engineered grades for direct compression and solid-dose work. That overlap links mannitol to the broader pharmaceutical excipient market, where flow, compactability and moisture behavior can determine whether a formulation scales cleanly from development to routine production.

Why do regulatory and qualification requirements slow substitution?

The restraint appears at qualification rather than at basic chemical availability. Food applications remain bounded by additive permissions and labeling rules, while pharmaceutical buyers qualify by route, dosage form, compendial status, impurity risk and supplier quality systems. Competition from the wider sugar substitute market also raises the performance threshold in reduced-sugar formulations. A lower purchase price does not offset revalidation work when a material change affects process performance or regulatory files.

Where do engineered pharmaceutical grades create higher-value opportunity?

The clearest opportunity is engineered pharmaceutical mannitol backed by auditable documentation. In June 2026, SPI Pharma reported completion of a nitrosamine risk assessment and analytical testing program for Mannogem. In April 2026, Mannitab Pharma Specialities received EXCiPACT GMP and GDP certification covering spray-dried and fine-powder mannitol grades. These actions address the quality and impurity-review burden that formulation teams manage before regular purchasing, giving documented direct-compression grades a stronger route into higher-value solid-dose programs.

Which country CAGRs are profiled in the Mannitol Market?

The profiled country CAGRs below cover 2026 to 2036.

Country	CAGR
South Korea	8.7%
UK	8.1%
USA	7.3%
Japan	6.1%
Germany	5.2%

How do country-level CAGRs compare in the Mannitol Market?

The profiled growth rates form three practical bands. South Korea and the UK sit above 8%, the USA is in the mid-7% range, and Japan and Germany expand more moderately. The difference between the highest and lowest profiled rates is 3.5 percentage points. These rates describe forecast pace rather than absolute market size. A faster CAGR can reflect a smaller starting base, channel expansion, or changing qualification conditions rather than a larger revenue pool.

• South Korea: A current additive code and an active import channel support a market where documentation and cross-border supply can translate into faster buying activity.
• UK: E421 remains an authorized sweetener, but food-specific limits keep formulation expertise and regulatory checking important for commercial use.
• USA: Food functionality is well established and pharmaceutical distribution is broadening, supporting demand across both conventional ingredient and excipient channels.
• Japan: A defined designated-additive framework and narrow food-use conditions make application selection more consequential than broad sweetener availability.
• Germany: EU polyol rules and mature pharmaceutical qualification standards favor compliant specialty use, but they also restrain rapid substitution in established formulations.

The country set should be read as a growth comparison rather than a ranking of market size. Coverage spans five profiled countries with different food rules, pharmaceutical practices, and distribution conditions.

Country-wise Analysis

• South Korea has the fastest profiled CAGR at 8.7% from 2026 to 2036. The Ministry of Food and Drug Safety published a consolidated Food Additives Code in July 2026, and an official import record shows a D-MANNITOL food-additive shipment cleared in March 2026. The combination of formal additive controls and an active import channel favors suppliers that can move current specifications, certificates and traceability records cleanly through the local buying process.
• The UK is profiled at an 8.1% CAGR from 2026 to 2036. A government additive list published in June 2026 identifies E421 as mannitol and notes that many additives remain subject to food-specific quantitative limits. Food manufacturers therefore need formulation support that links the grade to the permitted recipe, while pharmaceutical and nutraceutical customers apply a separate documentation test. Growth favors suppliers that can provide both consistent particle form and clear regulatory support.
• The USA is forecast to expand at a 7.3% CAGR from 2026 to 2036. FDA records list mannitol for several food functions and maintain route- and dosage-form based inactive-ingredient information for pharmaceutical use. In February 2026, Univar Solutions announced appointment as a distributor for Ingredion Pharma Solutions in the United States and Canada, covering pharmaceutical starches and specialty excipients including mannitol. Broader excipient access reinforces growth, but higher-value demand still depends on qualification evidence and technical service.
• Japan's profiled CAGR is 6.1% from 2026 to 2036. The market operates within a designated-additive system in which permitted substances and use standards matter at the application level. B Food Science Co. continues to position mannitol across selected food uses and a Japanese Pharmacopoeia grade. This makes application guidance central to selling: suppliers need to match the physical grade and regulatory route to a specific food or pharmaceutical use rather than rely on broad sweetener availability.
• Germany carries a 5.2% CAGR from 2026 to 2036. The country follows the current EU food-additive framework, which lists E421 mannitol as a sweetener with conditions of use, while pharmaceutical customers apply mature excipient qualification practices. Merck KGaA markets Parteck M for direct compression with major pharmacopoeial references. Germany therefore favors specification-led demand in the broader polyol sweetener market and in solid-dose manufacturing rather than rapid commodity substitution.

Who are the notable companies in the Mannitol Market?

Roquette Frères, SPI Pharma, Cargill, Merck KGaA, B Food Science Co., Ingredion Incorporated, Univar Solutions, Zhejiang Huakang Pharmaceutical Co., Ltd., American International Foods, and Foodchem International are the notable companies profiled in this market.

Competition separates into three practical positions. Pharmaceutical excipient specialists compete through compendial coverage, particle engineering and direct-compression performance. Food and polyol manufacturers compete through scale, food-grade availability and formulation familiarity. Distributors compete through local inventory, technical access and the ability to connect buyers with qualified excipient portfolios. Roquette Frères, SPI Pharma, Merck KGaA and Ingredion Incorporated anchor the specialty pharmaceutical side, while Cargill, B Food Science Co. and Zhejiang Huakang Pharmaceutical Co., Ltd. bring broader food and polyol capability. Univar Solutions, American International Foods and Foodchem International extend market access through distribution channels.

• Pharmaceutical excipient specialists: Roquette Frères, SPI Pharma, Merck KGaA, and Ingredion Incorporated compete around direct compression, particle engineering, compendial coverage, and formulation documentation.
• Food and polyol manufacturers: Cargill, B Food Science Co., and Zhejiang Huakang Pharmaceutical Co., Ltd. compete through food-grade availability, polyol manufacturing depth and application coverage.
• Distribution and ingredient channels: Univar Solutions, American International Foods, and Foodchem International compete through regional inventory, import access and broad ingredient portfolios.

Competitive Benchmarking: Mannitol Market

Company	Pharma-grade & compendial mannitol	Direct-compression / engineered grades	Food-grade / bulk sweetener channel	Geographic Reach
Roquette Frères	High	High	Medium	Europe, North America, and Asia-Pacific; China manufacturing is documented for PEARLITOL mannitol.
SPI Pharma	High	High	Low	North American base with international pharmaceutical channels documented by company materials.
Cargill	Medium	Unscored	High	Global ingredient network with documented EMEA mannitol supply.
Merck KGaA	High	High	Low	Global life-science channels with Germany-based corporate footprint and international excipient distribution.
B Food Science Co.	Medium	Low	High	Japan-focused food and pharmaceutical-grade mannitol supply.
Ingredion Incorporated	High	High	Medium	North America and Asia; India-based specialty mannitol manufacturing is documented.
Univar Solutions	Medium	Medium	Low	United States and Canada for the documented Ingredion Pharma Solutions distribution relationship.
Zhejiang Huakang Pharmaceutical Co., Ltd.	Medium	Low	High	China-based polyol manufacturing with international food and ingredient channels.
American International Foods	Unscored	Low	High	United States through a nationwide food-ingredient warehouse and distribution network.
Foodchem International	Unscored	Low	High	China-based international food-ingredient distribution.

Scoring basis: Pharma-grade & compendial mannitol rates the depth of dedicated pharmaceutical grades and pharmacopoeial or quality documentation. Direct-compression / engineered grades rates specialized particle or tableting capability. Food-grade / bulk sweetener channel rates commercial food-grade reach. High indicates broad capability, Medium indicates a narrower established position, and Unscored indicates that a capability is not rated in this benchmark.

Key Developments in the Mannitol Market

• In June 2026, Roquette Frères announced that China-manufactured PEARLITOL mannitol would be highlighted at CPHI China for oral, injectable, inhalation, and biologic formulation needs. The regional manufacturing point matters commercially because excipient buyers evaluate both technical suitability and continuity of supply. Local production can reduce reliance on long interregional replenishment routes for qualified grades.
• In April 2026, Mannitab Pharma Specialities received EXCiPACT GMP and GDP certification covering spray-dried and fine-powder mannitol grades. The certification strengthens the documented quality-system basis that pharmaceutical buyers can use during excipient approval and supplier review.

Key Players in the Mannitol Market

Pharmaceutical Excipient Specialists

• Roquette Frères
• SPI Pharma
• Merck KGaA
• Ingredion Incorporated

Food and Polyol Manufacturers

• Cargill
• B Food Science Co.
• Zhejiang Huakang Pharmaceutical Co., Ltd.

Distribution and Ingredient Channels

• Univar Solutions
• American International Foods
• Foodchem International

Mannitol Market - Report Scope

Coverage field	Report scope
Market breakdown	Form; End Use
Quantitative Units	USD Million
Market Definition	Revenue from mannitol ingredient and excipient sales within the stated Form and End Use universe. Downstream finished-product revenue and adjacent or substitute product revenue are excluded. Where mannitol is sold with formulation or distribution services, only the separable mannitol component is within scope; downstream services and aftermarket activity are excluded.
Regions Covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries Covered	USA; UK; Germany; Japan; South Korea
Key Companies Profiled	Roquette Frères; SPI Pharma; Cargill; Merck KGaA; B Food Science Co.; Ingredion Incorporated; Univar Solutions; Zhejiang Huakang Pharmaceutical Co., Ltd.; American International Foods; Foodchem International
Forecast Period	2026 to 2036
Approach	Primary and secondary research with market triangulation.

Mannitol Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments and findings from primary interviews. Validation also tested whether products, services, applications and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Mannitol Market by Segments

Mannitol Market segmented by Form:

• Crystal
• Powder

Mannitol Market segmented by End Use:

• Food
• Beverages
• Pharmaceuticals
• Carbonated Drinks
• Bakery Goods
• Confectionery
• Powdered Drinks and Mixes
• Solid dosage forms

Mannitol Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• U.S. Food and Drug Administration (2026, July 28). Substances Added to Food (formerly EAFUS): MANNITOL.
• U.S. Food and Drug Administration (n.d.). Inactive Ingredients Database Download.
• UK Government (2026, June 25). Approved additives and E numbers.
• European Commission (2026, February 18). Consolidated EU food-additives rules listing E421 Mannitol and current conditions of use.
• Ministry of Health, Labour and Welfare, Japan (n.d.). Food Additives.
• B Food Science Co. (n.d.). Mannitol.
• Ministry of Food and Drug Safety, South Korea (2026, July 13). Food Additives Code, Notice No. 2026-50.
• Ministry of Food and Drug Safety, South Korea (2026, March 27). D-MANNITOL import record.
• Roquette Frères (2026, June 10). Roquette Showcases Drug Delivery Innovations at CPHI China 2026.
• SPI Pharma (2026, June 4). SPI Pharma Completes Nitrosamine Testing Program for Mannogem.
• Ingredion Pharma Solutions (2026, April). Mannitab achieves EXCiPACT certification.
• Univar Solutions (2026, February 24). Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada.
• European Commission (2026, February 5). Food additives in the EU: safe use and clear labelling.
• European Commission Knowledge4Policy (2026, January 9). Main sweeteners and their sources.
• FoodPro (2026). Mannitol - Zhejiang Huakang Pharmaceutical Co., Ltd.
• Ingredion Pharma Solutions (n.d.). Ingredion announces investments in Pharma.
• Ingredion Pharma Solutions (n.d.). MANNITAB SD1: Spray Dried Mannitol.
• Cargill (n.d.). C Mannidex Mannitol.
• Merck KGaA (n.d.). Parteck M (Mannitol) Excipients.
• SPI Pharma (n.d.). Compendial Mannitol: Mannogem Mannitol.
• American International Foods (n.d.). Mannitol.
• Foodchem International (n.d.). Mannitol.
• Zhejiang Huakang Pharmaceutical Co., Ltd. (n.d.). Functional polyol manufacturing and product portfolio.
• Univar Solutions (n.d.). MANNITAB F1 (Mannitol Powder).

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How large is the Mannitol Market in 2026, and what value is forecast for 2036?
• Which industry pressures are supporting demand for mannitol across food and pharmaceutical applications?
• Why does Crystal lead the Form category in 2026?
• Why does Food lead the End Use category in 2026?
• How do profiled country growth rates differ between South Korea, the UK, the USA, Japan, and Germany?
• Which companies supply or distribute relevant mannitol product categories?
• What limits adoption or supplier switching in regulated food and pharmaceutical applications?
• What should buyers evaluate before purchasing food-grade or pharmaceutical-grade mannitol?